If you are a qualified healthcare professional, you can access medicines through Early Access Programs (also known as expanded access, named patient, compassionate use and managed access). Inceptua is running in partnership with pharmaceutical clients.
Inceptua is supporting a large number of pharmaceutical and biotech companies through its management of Early Access Programs for their assets.
Currently Inceptua is managing programs covering a wide range of rare diseases, oncolog and infectious diseases , allowing physicians to access these medicines prior to their commercial approval.
The full list of ongoing pre-approval access programs being managed by Inceptua, along with their inclusion criteria, and geographic scope, can be viewed by registering with our IMAP portal
SUPPORTING YOU THROUGH THE ENTIRE PROCESS
- Ethical and compliant
- Directly partnered with the manufacturer
- Dedicated country expert Medicines Access Advisors
- Available by mail or phone
- Local language support
- Unparalleled regulatory guidance
- Easy-to-use online platform
- Global network of warehouses
- Rapid Response and delivery
Access Portal
For US physicians please contact us at: access.us@inceptua.com
For physicians outside of the US please contact us at: access@inceptua.com